Altered gene expression patterns in resistant cells might reveal epigenetic based survival mechanisms.
Therapies aimed at prolonging the survival of fully matured effectors should enhance the efficacy of T cell based immunotherapies.
Three rats in the 2 week survival group and 4 rats in the 6 week survival group were found to contain human cells based on the specific human nuclear antigen (hNUC).
Furthermore, the survival rates of air-blast dried yeast cells, based on the amount of lactomil added, were investigated and all samples mixed with 7 g lactomil statistically showed the highest and optimal survival rate (Table 2).
Survival was evaluated by comparing oocyte morphology upon freeze-thaw with that of fresh cells (based on microscopic observation).
To search for small molecules that possess robust TrkB agonistic activity, here, we invented a cell-based survival functional assay.
Within the scope of the protodynamic therapy concept, our study suggests a novel mechanism for cis-UCA-induced inhibition of cancer cell survival, based upon compromised signalling and metabolic functions and cell cycle arrest leading to apoptotic and necrotic cell death.
A data driven, multivariate approach, was used in this study to predict prostate cancer cell survival based on the phosphorylation levels of key proteins in PC3, LNCaP, and MDA-PCa-2b cell lines in response to EGF, IGF1, IL6, TNFα, dihydrotestosterone, and docetaxel treatment.
Therefore, general cell death assays were used, such as MTT or CellTiterGlo™ (chemoluminescence), which determine the extent of cell survival based on mitochondrial activity, as well as an ELISA assay which quantifies DNA fragmentation (Walter et al. 2008; Schmich et al. 2011).
This was not due to changes in cell survival based on the similar clonogenic frequencies between FAK+/+ or FAK-/ v-Src clones expressing the paxillinY118F allele (Fig. 5A, right middle panel).
